Ready To Welcome To...
Health Care: Drugs
Raptor Pharmaceutical Corp (RPTP: NASDAQ)
$6.65 0.11 | 1.68%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -38.64M | -37.19M | -18.93M | -9.22M |
| Operating Gains/Losses | 0.00 | 0.00 | -7.85K | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 754.00K | 209.82K | 23.74K | 47.98K |
| (Decrease) Increase In Other Current Liabilities | 403.00K | 1.12M | -2.26K | 18.81K |
| (Increase) Decrease In Other Working Capital | -10.00K | 19.46K | -27.00 | -2.95K |
| Other Non-Cash Items | 8.63M | 18.53M | 6.19M | 402.59K |
| Net Cash From Continuing Operations | -31.35M | -17.22M | -12.58M | -8.53M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -31.35M | -17.22M | -12.58M | -8.53M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 30.00M | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -378.00K | -49.42K | -20.76K | -22.73K |
| Acquisitions | 0.00 | 0.00 | 581.39K | 0.00 |
| Purchases of Short-Term Investments | -45.31M | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -54.00K | -114.47K | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -15.74M | -163.89K | 560.64K | -22.73K |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 59.06M | 15.75M | 27.99M | 5.00M |
| Repayment of Long-Term Debt | -5.00K | -4.86K | -4.12K | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -3.51M | -151.78K | -2.72M | -297.16K |
| Net Cash From Financing Activities | 55.55M | 15.59M | 25.27M | 4.70M |
| Effect of Exchange Rate Changes | -52.00K | 9.76K | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 8.41M | -1.78M | 13.25M | -3.85M |
Portfolios with RPTP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
- UserNew
- ContributorUnder-$10 Setting Up To Tra...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserTrashy77 - 20110803
- ContributorHeavily Shorted Market Lead...
Latest RPTP Headlines from TheStreet
- Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results 05.08.13 | 04:05 pm
- Raptor Pharmaceutical Licenses Intellectual Property For Rett Syndrome From French Research Institutes 05.07.13 | 07:05 am
- 5 Stocks Under $10 Set to Surge 05.02.13 | 02:05 pm
- Raptor's FDA Approval Is New Test For Orphan Drug Pricing 05.01.13 | 07:05 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Raptor Pharmaceutical Corp. Reports Financial Results For The Transition Period From September 1, 2012 To December 31, 2012 03.14.13 | 04:03 pm
- 5 Stocks Under $10 Set to Soar 03.07.13 | 01:03 pm
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- Raptor Pharmaceutical Corp. To Present At The Cowen And Company 33rd Annual Health Care Conference 02.26.13 | 05:02 pm
- Raptor Pharmaceutical Corp. To Present At Upcoming Investor Conferences 02.05.13 | 04:02 pm
Press Releases for RPTP
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Raptor Pharmaceuticals Corp. - Business Wire 02.12.13 | 10:02 am
- Faruqi & Faruqi, LLP Is Investigating Raptor Pharmaceutical Corporation On Behalf Of Its Shareholders - RPTP - PR Newswire 02.12.13 | 08:02 am
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Raptor Pharmaceuticals Corp. In Connection With Executive Compensation - PR Newswire 01.23.13 | 02:01 pm
- HealthCare Royalty Partners Commits Over $300 Million In New Investments In December And Over $425 Million In 2012 - PR Newswire 01.03.13 | 08:01 am
Partner Headlines for RPTP
- Raptor To Rise On Proven Strategy & Upcoming FDA Decision - Seeking Alpha 12.28.12 | 09:12 am
- Three Compelling Biopharma Stocks For 2013 - Seeking Alpha 12.26.12 | 09:12 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Raptor Pharmaceutical Announces Publication of Phase 3 Results in the Clinical Journal of the American Society of Nephrology - Benzinga 05.03.12 | 01:05 pm
- Raptor Pharmaceutical Stockholder Meeting Adjourned due to Lack of Requisite Quorum - Benzinga 04.26.12 | 01:04 pm
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.09.12 | 04:03 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Raptor Pharmaceuticals Provides Update On Lead Candidate: RP103 - Seeking Alpha 10.31.11 | 08:10 am
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
